<DOC>
	<DOCNO>NCT00785694</DOCNO>
	<brief_summary>This randomise , comparative , multicentre study determine early recurrence rate intermediate-risk bladder cancer similar subject treat multiple instillation mitomycin C resection conduct white light cystoscopy ( group A ) subject treated 1 instillation mitomycin C resection conduct white light blue light cystoscopy ( group B ) .</brief_summary>
	<brief_title>Recurrence Bladder Cancer After Transurethral Resection With Hexvix</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>The subject childbearing potential sign informed consent . Subject 1 primary bladder tumour , confirm outpatient cystoscopy subject 1 recurrent bladder tumour appear within 12 month removal previous bladder tumour , confirm outpatient cystoscopy . The subject previously include study . The subject history/is suspect TaG3 great equal T1 tumour carcinoma situ ( CIS ) . The subject suspect single primary single recurrent TaG1 tumours recurrence occur 1 year initial diagnosis previous recurrence . The subject know tumour prostatic urethra , distal urethra , upper urinary tract . The subject gross haematuria . The subject history porphyria .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>